AUB -Study the Frequency of Endometrial Hyperplasia in Women Under Abortion Referred to Imam Reza Hospital AS with Abnormal Bleeding AUB Year 2015-2016

Backgrounds: Endometrial hyperplasia occurs when the endometrium, the lining of the uterus, becomes too thick. It is not cancer, but in some cases, it can lead to cancer of the uterus. The most striking symptom of this is abnormal uterine bleeding (AUB) during and around menopause.The aim of this study is Determine frequency of endometrial hyperplasia in women under abortion referred to Imam Reza Hospital (AS) with abnormal bleeding (AUB) year 2015-2016.Material and method : This is a descriptive-analytic study, that was conducted on women with abnormal bleeding referred to Imam Reza Hospital in the years 2015-2016 and underwent curettage. Ages 45 to 55 years around menopause and after menopause is aged over 55 years. After completing the information in the checklist, the information was entered into the statistical software of spss version 16 and analyzed.Result: 576 patients with abnormal uterine bleeding and under diagnostic curettage were studied. 141 patients had hyperplasia on the basis of pathology, which is equivalent to 24.47% of the above cases. 141 patients underwent three groups, before menopause(19.9%), around menopause(74.46%) and post menopause ( 5.7%). The prevalence of endometrial hyperplasia was more common in adolescents and menopausal intelligence. There was no statistically significant difference between mean age of patients in hyperplasia groups (P = 0.698). In general, 44.7% of cases are simple hyperplasia, 27% complex, 17.7% a complex atepic and 10.6% simple atepic. There was no statistically significant difference in the types of hyperplasia in the three groups before, after and after menopause.Conclusion: The incidence of hyperplasia in women with abnormal bleeding, under diagnostic curettage is 24.47%. The majority of cases of hyperplasia are simple hyperplasia.There was no statistically significant statistical difference in the types of hyperplasia in the three groups before, around, and after menopause.